Journal Article

<i>BCRP</i> gene polymorphisms are associated with susceptibility and survival of diffuse large B-cell lymphoma

Li-Li Hu, Xiao-Xiao Wang, Xiaochao Chen, Jianhua Chang, Caixia Li, Yan Zhang, Jine Yang, Wenqi Jiang and Shi-Mei Zhuang

in Carcinogenesis

Volume 28, issue 8, pages 1740-1744
Published in print August 2007 | ISSN: 0143-3334
Published online May 2007 | e-ISSN: 1460-2180 | DOI:
BCRP gene polymorphisms are associated with susceptibility and survival of diffuse large B-cell lymphoma

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics


Show Summary Details


To date, the biological significance of breast cancer resistance protein (BCRP) G34A and C421A polymorphisms is largely unknown. Analysis of these two polymorphisms in 156 diffuse large B-cell lymphoma (DLBCL) patients and 376 control subjects revealed an increased risk of DLBCL associated with variant BCRP 421 genotypes (CA and AA), when compared with the wild-type CC genotype [odds ratio = 1.49, 95% confidence interval (CI) 1.02–2.17, P = 0.042]. Moreover, the increased risk was more evident in younger patients (≤50 years, odds ratio = 2.14, 95% CI 1.25–3.68, P = 0.006). Further evaluation for the association of these polymorphisms with overall survival of DLBCL showed that patients with 34AA alleles displayed worse survival compared with those carrying GG/GA genotypes [hazard ratio (HR) = 3.69, 95% CI 1.56–8.71, P = 0.001]. Significant association between 421CC genotypes and poorer survival of DLBCL was observed in patients younger at diagnosis (≤50 years, HR = 5.80, 95% CI 1.16–28.90, P = 0.015) or with bulky tumor (HR = 4.36, 95% CI 1.04–18.31, P = 0.027). Furthermore, we found the combined effects of BCRP G34A and C421A on the overall survival. Compared with patients carrying BCRP 34(GG + GA)421(AA + CA) genotype, the individual with 34AA421CC displayed the worst survival (HR = 7.55, 95% CI 2.36–24.17, P = 0.001), while those with 34(GG + GA)421CC and 34AA421(AA + CA) combinations showed the intermediate survival. These results suggest that the BCRP G34A and C421A polymorphisms are associated with the risk and survival of DLBCL. Our finding warrants further investigations on the association of BCRP polymorphisms with susceptibility and clinical outcome of cancer.

Journal Article.  3167 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.